For gastroenterologists
Stratify gastric-cancer risk — before the scope.
Chronic atrophic gastritis is silent, and scoping every dyspeptic isn't feasible. A four-marker blood panel flags the atrophic stomach non-invasively.
- Non-invasive read on the stomach lining — pepsinogen I, pepsinogen II, gastrin-17 and H. pylori antibody, read together
- Prioritise who most warrants endoscopy
- Risk-stratification before symptoms force a scope
Biohit
GastroPanel Unified
A four-marker blood panel that pictures the health of the stomach mucosa — non-invasively.
Stratifies gastric-cancer risk by flagging atrophic gastritis non-invasively, helping prioritise who warrants endoscopy — risk-stratification before the scope.
Full clinical details →Get the details
Leave your details and we'll send the method note and a quote for your setting.